FDA Approvals - In Practice

FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Patients on venetoclax for CLL, SLL, or AML often need antifungal prophylaxis — but azole antifungals complicate dosing. New guidance on how to optimize safety and efficacy.

Dr. Grant Drew et al. April 16, 2026

All FDA Approvals

FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Dr. Grant Drew et al. April 16, 2026

FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026